Lv5
1270 积分 2024-07-28 加入
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
1天前
待确认
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study
14天前
已完结
Thrombolysis-to-Puncture Time Determines the Differential Effect of Tenecteplase Versus Alteplase in Large Vessel Occlusion
4个月前
已完结
Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion
7个月前
已完结
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial
7个月前
已完结
Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke
7个月前
已完结
Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Acute Stroke
7个月前
已完结
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
9个月前
已完结
Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke
10个月前
已完结
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial
10个月前
已完结
皖公网安备34019202002308
